Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 11 | 15 | +4 |
| Shares | 96.8K | 372.9K | +276.1K (+285.4%) |
| Value | $199.3K | $540.7K | +$341.4K (+171.2%) |
New holders (7)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 135,170 | $196.0K | 0.00% |
| Anson Funds Management LP | 105,549 | $153.0K | 0.01% |
| Armistice Capital, LLC | 42,000 | $60.9K | 0.00% |
| Global Retirement Partners, LLC | 4,118 | $5.97K | 0.00% |
| Harbour Investments, Inc. | 224 | $325 | 0.00% |
| Bogart Wealth, LLC | 100 | $145 | 0.00% |
| Barclays PLC | 54 | $78 | 0.00% |
Sold out (3)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Susquehanna International Group, LLP | 10,469 | $21.6K |
| Wells Fargo & Company | 5,000 | $10.3K |
| FMR LLC | 250 | $515 |